首页> 美国卫生研究院文献>Integrative and Comparative Biology >Here We Are But Where Do We Go? A Systematic Review of Crustacean Transcriptomic Studies from 2014–2015
【2h】

Here We Are But Where Do We Go? A Systematic Review of Crustacean Transcriptomic Studies from 2014–2015

机译:我们在这里但我们要去哪里? 2014-2015年甲壳动物转录组学研究的系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite their economic, ecological, and experimental importance, genomic resources remain scarce for crustaceans. In lieu of genomes, many researchers have taken advantage of technological advancements to instead sequence and assemble crustacean transcriptomes de novo. However, there is little consensus on what standard operating procedures are, or should be, for the field. Here, we systematically reviewed 53 studies published during 2014–2015 that utilized transcriptomic resources from this taxonomic group in an effort to identify commonalities as well as potential weaknesses that have applicability beyond just crustaceans. In general, these studies utilized RNA-Seq data, both novel and publicly available, to characterize transcriptomes and/or identify differentially expressed genes (DEGs) between treatments. Although the software suite Trinity was popular in assembly pipelines and other programs were also commonly employed, many studies failed to report crucial details regarding bioinformatic methodologies, including read mappers and the utilized parameters in identifying and characterizing DEGs. Annotation percentages for assembled transcriptomic contigs were low, averaging 32% overall. While other metrics, such as numbers of contigs and DEGs reported, correlated with the number of sequence reads utilized per sample, these did reach apparent saturation with increasing sequencing depth. Most disturbingly, a number of studies (55%) reported DEGs based on non-replicated experimental designs and single biological replicates for each treatment. Given this, we suggest future RNA-Seq experiments targeting transcriptome characterization conduct deeper (i.e., 50–100 M reads) sequencing while those examining differential expression instead focus more on increased biological replicates at shallower (i.e., ∼10–20 M reads/sample) sequencing depths. Moreover, the community must avoid submitting for review, or accepting for publication, non-replicated differential expression studies. Finally, mining the ever growing publicly available transcriptomic data from crustaceans will allow future studies to focus on hypothesis-driven research instead of continuing to simply characterize transcriptomes. As an example of this, we utilized neurotoxin sequences from the recently described remipede venom gland transcriptome in conjunction with publicly available crustacean transcriptomic data to derive preliminary results and hypotheses regarding the evolution of venom in crustaceans.
机译:尽管它们具有经济,生态和实验重要性,但是对于甲壳类动物而言,基因组资源仍然稀缺。代替基因组,许多研究人员已经利用技术进步来代替从头测序和组装甲壳类转录组。但是,对于该领域应该使用或应该使用什么标准操作程序,人们几乎没有共识。在这里,我们系统地回顾了2014-2015年间发表的53项研究,这些研究利用了该分类学组的转录组学资源,以试图找出共同性以及除了甲壳类动物以外还具有适用性的潜在弱点。通常,这些研究利用新颖且可公开获得的RNA-Seq数据来表征转录组和/或鉴定治疗之间的差异表达基因(DEG)。尽管Trinity软件套件在装配流水线中很流行,并且也普遍采用了其他程序,但是许多研究未能报告有关生物信息学方法的关键细节,包括读取映射器以及用于识别和表征DEG的参数。组装的转录组重叠群的注释百分率很低,总体平均为32%。虽然其他指标(例如报告的重叠群和DEG数量)与每个样品使用的序列读数数量相关,但随着测序深度的增加,这些指标确实达到了明显的饱和度。最令人不安的是,许多研究(55%)报告了基于非重复实验设计和每种疗法的单个生物学重复的DEG。鉴于此,我们建议将来针对转录组表征的RNA-Seq实验进行更深的测序(即50–100 M读数),而那些检查差异表达的实验则更多地关注于较浅的(即,约10–20 M读数/样品)增加的生物复制。 )排序深度。此外,社区必须避免提交非复制性差异表达研究以供审查或接受发表。最后,从甲壳类动物中获取越来越多的可公开获得的转录组数据,将使未来的研究专注于假设驱动的研究,而不是继续简单地表征转录组。例如,我们利用最近描述的重毒蛇毒腺转录组中的神经毒素序列,与可公开获得的甲壳动物转录组数据相结合,得出有关甲壳动物毒液进化的初步结果和假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号